Dimberg A

Keeping Wnt in check for efficient checkpoint blockade in glioblastoma.

Melssen M, Dimberg A

Proc. Natl. Acad. Sci. U.S.A. 122 (44) e2523639122 [2025-11-04; online 2025-10-27]

Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domains.

Barbera S, Schuiling MJA, Sanjaya NA, ..., Essand M, Dimberg A

Sci Immunol 10 (103) eado2054 [2025-01-31; online 2025-01-31]

Cellular and molecular events organizing the assembly of tertiary lymphoid structures in glioblastoma

Vaccaro A, Yang F, van de Walle T, ..., Ramachandran M, Dimberg A

- - (-) - [2024-07-06; online 2024-07-06]

Author Correction: A method for Boolean analysis of protein interactions at a molecular level.

Raykova D, Kermpatsou D, Malmqvist T, ..., Kampf C, Söderberg O

Nat Commun 14 (1) 5450 [2023-09-06; online 2023-09-06]

Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.

Sun Y, Chen W, Torphy RJ, ..., Chen L, Zhu Y

Sci Transl Med 13 (604) - [2021-07-28; online 2021-07-30]

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.

van Hooren L, Vaccaro A, Ramachandran M, ..., Essand M, Dimberg A

Nat Commun 12 (1) 4127 [2021-07-05; online 2021-07-05]

Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma

van Hooren L, Vaccaro A, Ramachandran M, ..., Essand M, Dimberg A

- - (-) - [2021-01-06; online 2021-01-06]

Tumor angiogenesis: causes, consequences, challenges and opportunities.

Lugano R, Ramachandran M, Dimberg A

Cell. Mol. Life Sci. 77 (9) 1745-1770 [2020-05-00; online 2019-11-06]

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Georganaki M, Ramachandran M, Tuit S, ..., Tugues S, Dimberg A

Oncoimmunology 9 (1) 1730538 [2020-03-09; online 2020-03-09]